Semaglutide, initially designed for type 2 diabetes treatment, is now utilized for both diabetes control and weight loss. Monitoring blood glucose levels and assessing diabetes symptoms are crucial aspects of the clinical panel involving Semaglutide. For weight management, a lower dose of Semaglutide is approved, impacting appetite control. Nausea, vomiting, and diarrhea are potential side effects. Regular monitoring is essential for evaluating Semaglutide’s effectiveness in managing blood sugar and supporting optimal diabetes control and weight loss under healthcare professional guidance.